Access the full text.
Sign up today, get DeepDyve free for 14 days.
L. Candelise, E. Aritzu, A. Ciccone, S. Ricci, J. Wardlaw, G. Tognoni, M. Roncaglioni, E. Negri, F. Colombo, E. Boccardi, C. Degrandi, G. Scialfa, C. Argentino, V. Bertele', A. Maggioni, P. Perrone, H. Barnett, J. Bogousslavsky, A. Delfavero, U. Loi, R. Peto, C. Warlow, S. Canzi, S. Comparetti, F. Clerici, A. Palumbo, G. Sgaroni, S. Polonara, R. Reginelli, M. Ceravolo, L. Provinciali, M. Delgobbo, O. Scarpino, E. Bottacchi, G. Dalessandro, M. Digiovanni, S. Blanc, L. Roveyaz, L. Ralli, D. Vanni, C. Refi, F. Federico, C. Conte, V. Inchingolo, R. Insabato, F. Salsa, A. Lorizio, M. Rottoli, L. Bruni, C. Defanti, L. Fera, M. Camerlingo, L. Casto, B. Censori, A. Mamoli, D. Porazzi, G. Grampa, I. Laspina, L. Giglia, V. Avenia, S. Gueli, V. Lolli, V. Miele, M. Santangelo, G. Coppola, G. Trianni, M. Marra, E. Greco, D. Tonti, E. Pretolani, M. Stellio, M. Arnaboldi, R. Ciola, G. Danieli, M. Rezzonico, M. Guidotti, G. Pellegrini, F. Raudino, C. Delfavero, T. Frattini, T. Riccardi, C. Leviminzi, F. Locatelli, F. Passeri, G. Lombardo, F. Cocco, M. Pratesi, S. Santini, F. Cardopatri, O. Tafani, G. Landini, E. Pieragnoli, R. Bellesi, L. Bagnoli, A. Ghetti, O. Marrazza, P. Menegazzo, S. Spolveri, C. Cappelletti, G. Candeliere, G. Costantino, F. Dacuno, T. Lomuzio, F. Rizzitelli, G. Bovio, G. Grilli, M. Zocchi, I. Mazzanti, G. Pisapia, R. Nuzzi, G. Russo, G. Lama, G. Baldassarri, R. Bettini, E. Cani, E. Cerioli, M. Degiorgi, A. Garagnani, S. Pasquali, V. Chioma, C. Fini, G. Marzara, A. Balotta, D. Bertuzzi, M. Masina, C. Matacena, M. Michelini, G. Pirazzoli, C. Sacchet, P. Marotta, L. Calvi, C. Scaccabarozzi, C. Menozzi, F. Sasanelli, C. Bascelli, V. Pontrelli, F. Schieroni, D. Belvedere, E. Decapitani, M. Dicostanzo, M. Rascaroli, O. Citterio, R. Milani, R. Capialbi, G. Arena, R. Musolino, R. Diperri, C. Bonaventi, F. Finzi, A. Messina, V. Romanazzi, R. Sterzi, G. Bottini, I. Santilli, A. Brucato, E. Dejuli, G. Palmieri, S. Ragaini, G. Thiella, C. Alli, L. Carosella, G. Rizzato, M. Bianchi, C. Motto, G. Pinardi, G. Scarlato, A. Bettinelli, F. Porro, A. Randazzo, U. Marini, P. Lattuada, A. Pietra, M. Franceschi, M. Voloute, G. Malferrari, M. Bondi, W. Garuti, L. Melini, A. Colombo, G. Alborini, P. Panzetti, M. Scarpa, P. Sorgato, G. Crisi, N. Bonasera, F. Basso, E. Natali, P. Monaco, A. Gasparro, F. Triolo, A. Lechi, F. Colonna, I. Dascola, C. Giorgi, U. Scoditti, P. Bassi, R. Menozzi, P. Piazza, G. Degliantoni, M. Desimoni, A. Giannini, G. Micili, D. Bosone, A. Cavallini, A. Martelli, F. Barzizza, M. Poli, S. Biagini, G. Capocchi, M. Celani, A. Picchiarelli, E. Righetti, M. Zampolini, N. Caputo, S. Bartolini, M. Santoni, D. Sita, M. Taglioli, G. Volpi, F. Rossi, F. Aloy, A. Castellano, F. Minotta, A. Gatta, A. Vinattieri, A. Cantini, G. Rebucci, G. Bissi, F. Deblasi, E. Pascarelli, F. Turiamo, D. Guidetti, M. Baratti, G. Ferrarini, E. Ghidoni, G. Greco, N. Marcello, L. Motti, F. Solimé, S. Terenziani, R. Zucco, A. Troiso, M. Veneziani, I. Iori, L. Curatola, G. Bollettini, T. Carboni, R. Gobbato, P. Infricciolo, D. Sabatini, M. Sfrappini, A. Fancellu, G. Casu, M. Deledda, M. Spanu, A. Pirisi, F. Marras, G. Rosati, A. Brambilla, G. Erli, B. Felice, R. Grandi, D. Mirabile, M. Zadra, R. Cavestri, D. Gori, E. Longhini, N. Miele, G. Divizia, S. Grasselli, F. Pezzella, F. Zuccari, L. Sallusto, F. Lincesso, C. Scarpati, G. Iannone, A. Bartocci, F. Costantini, L. Desantis, G. Lancia, E. Moschini, A. Paci, A. Sensidoni, A. Trenta, N. Bartolini, P. Ottaviano, B. Biscottini, G. Alunni, I. Bartolini, D. Belladonna, A. Boccali, M. Cruciani, R. Ibba, R. Luccioli, A. Marceca, M. Pacini, M. Pallone, P. Girardi, D. Orrico, E. Lanza, A. Ballini, F. Grandi, G. Musco, L. Steidl, G. Santoro, A. Vemco, P. Dudine, F. Milone, L. Munari, A. Perreti, M. Porta, C. Longoni, R. Ferani, M. Watt, P. Sandercock, A. Fennetry, P. Bannister, C. Clarke, J. Bamford, G. Venables, M. Correia (1995)
RANDOMIZED CONTROLLED TRIAL OF STREPTOKINASE, ASPIRIN, AND COMBINATION OF BOTH IN TREATMENT OF ACUTE ISCHEMIC STROKEThe Lancet, 346
A. Morris, C. Ritchie, D. Grosset, F. Adams, K. Lees (1995)
A pilot study of streptokinase for acute cerebral infarction.QJM : monthly journal of the Association of Physicians, 88 10
J. Malone‐Lee, A. Wagg, A. Mundy, C. Fry, J. Lincoln, A. Naylor (1994)
Science of urinary incontinence Report of a Meeting of Physicians and Scientists, University College LondonThe Lancet, 344
M. Yasaka, G.J. O’Keefe, B.R. Chambers (1998)
Streptokinase in acute stroke: effect on reperfusion and recanalisationNeurology, 50
A. Jaillard, C. Cornu, Anne Durieux, T. Moulin, F. Boutitie, K. Lees, M. Hommel (1999)
Hemorrhagic transformation in acute ischemic stroke. The MAST-E study. MAST-E Group.Stroke, 30 7
W.M. Clark, G.W. Albers, K.P. Madden (2000)
The rtPA (Alteplase) 0- to 6-Hour acute stroke trial, Part A (A0276g) Results of a double-blind, placebo-controlled, multicenter studyStroke, 31
D. Toni, M. Fiorelli, M. Gentile (1995)
Progressing neurological deficit secondary to acute ischaemic strokeArch Neurol, 52
B. Infeld, S. Davis, G. Donnan, M. Lichtenstein, A. Baird, D. Binns, P. Mitchell, J. Hopper (1996)
Streptokinase increases luxury perfusion after stroke.Stroke, 27 9
Takenori Yamaguchi, T. Hayakawa, Haruhiko Kiuchi (1993)
Intravenous Tissue Plasminogen Activator Ameliorates the Outcome of Hyperacute Embolic StrokeCerebrovascular Diseases, 3
C. Murray, Alan Lopez (1997)
Mortality by cause for eight regions of the world: Global Burden of Disease StudyThe Lancet, 349
(1997)
Intracerebral hemorrhage after intravenous t-PA therapy for ischemic strokeStroke, 28
W. Clark, G. Albers, K. Madden, S. Hamilton (2000)
The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g) : results of a double-blind, placebo-controlled, multicenter study. Thromblytic therapy in acute ischemic stroke study investigators.Stroke, 31 4
D. Altman, Jonathon Deeks, D. Sackett (1998)
Odds ratios should be avoided when events are commonBMJ, 317
A. Baird, C. Austin, J. McKay, Donnan Department, Baird Donnan, M. Austin, W. Mckay, Professor Donnan (1996)
Changes in cerebral tissue perfusion during the first 48 hours of ischaemic stroke: relation to clinical outcome.Journal of Neurology, Neurosurgery & Psychiatry, 61
J. Baron (2001)
Perfusion Thresholds in Human Cerebral Ischemia: Historical Perspective and Therapeutic ImplicationsCerebrovascular Diseases, 11
W. Clark, Stanley Wissman, G. Albers, J. Jhamandas, K. Madden, S. Hamilton (1999)
Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.JAMA, 282 21
W. Hacke, M. Kaste, C. Fieschi (1998)
Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). European Cooperative Acute Stroke Study IILancet, 352
P. Sandercock, R. Collins, C. Counsell, B. Farrell, R. Peto, J. Slattery, C. Warlow, S. Anderson, A. Bowie, J. Boyle, A. Brownlie, D. Charlton, G. Cranswick, L. Day, M. Dennis, P. Dorman, H. Fraser, M. Kaye, R. Lindley, M. Liu, C. Macdonald, I. McCrindle, G. Middleton, D. Perry, V. Scoltock, Brenda Smith, H. Taylor, F. Waddell, J. Wardlaw, J. Crowther, J. Heineman, S. Knight, A. Radley, R. Ripley, S. Richards, S. Wilberforce, Zhengming Chen, J. Vangijn, Michael Harrison, L. Wilhelmsen (1997)
The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic strokeThe Lancet, 349
C. Stefanadis, P. Toutouzas (1995)
Percutaneous implantation of autologous vein graft stent for treatment of coronary artery diseaseThe Lancet, 345
(1994)
Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients [published erratum appears in Lancet 1994; 343:742]Lancet, 343
A. Buchan, P. Barber, Nancy Newcommon, H. Karbalai, A. Demchuk, K. Hoyte, G. Klein, T. Feasby (2000)
Effectiveness of t-PA in acute ischemic strokeNeurology, 54
M. Cucherat, J. Boissel, A. Leizorovicz, M. Haugh (1997)
EasyMA: a program for the meta-analysis of clinical trials.Computer methods and programs in biomedicine, 53 3
W.M. Clark, S. Wissman, G.W. Albers (1999)
Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: A randomized controlled trialJAMA, 282
J. Herlitz (1994)
Indications for fibrinolytic therapy in suspected acute myocardial infarction : collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patientsThe Lancet, 343
Zhengming Chen (1997)
CAST: randomised placebo-controlled trial of early aspirin use in 20 000 patients with acute ischaemic strokeThe Lancet, 349
A. Furlan, R. Higashida, L. Wechsler, M. Gent, H. Rowley, C. Kase, M. Pessin, A. Ahuja, F. Callahan, W. Clark, F. Silver, F. Rivera (1999)
Intra-arterial Prourokinase for Acute Ischemic Stroke: The PROACT II Study: A Randomized Controlled TrialJAMA, 282
C. Cornu, F. Boutitie, L. Candelise, J. Boissel, G. Donnan, Marc Hommel, A. Jaillard, K. Lees (2000)
Streptokinase in acute ischemic stroke: an individual patient data meta-analysis : The Thrombolysis in Acute Stroke Pooling Project.Stroke, 31 7
John Sinclair, Michael Bracken (1994)
Clinically useful measures of effect in binary analyses of randomized trials.Journal of clinical epidemiology, 47 8
W.M. Clark, G.W. Albers (1999)
The ATLANTIS rt-PA (Alteplase) acute stroke trial: final results [abstract]Cerebrovasc Dis, 9
G.A. Donnan, S.M. Davis, B.R. Chambers (1996)
Streptokinase for acute ischaemic stroke with relationship to time of administrationJAMA, 276
G.J. Zoppo, R.T. Higashida, A.J. Furlan (1998)
PROACT: A phase II randomised trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery strokeStroke, 29
I. Katzan, A. Furlan, L. Lloyd, J. Frank, D. Harper, J. Hinchey, J. Hammel, Annie Qu, C. Sila (2000)
Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience.JAMA, 283 9
M. Yasaka, G. O'Keefe, B. Chambers, S. Davis, B. Infeld, H. O'Malley, A. Baird, T. Hirano, G. Donnan (1998)
Streptokinase in acute strokeNeurology, 50
R. Galbraith (1988)
A note on graphical presentation of estimated odds ratios from several clinical trials.Statistics in medicine, 7 8
W. Hacke, M. Kaste, C. Fieschi, D. Toni, E. Lesaffre, R. Kummer, G. Boysen, E. Bluhmki, G. Höxter, M. Mahagne (1995)
Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)JAMA, 274 13
M. Grond, C. Stenzel, S. Schmülling, Jobst Rudolf, M. Neveling, A. Lechleuthner, S. Schneweis, W. Heiss (1998)
Early intravenous thrombolysis for acute ischemic stroke in a community-based approach.Stroke, 29 8
C. Fieschi, C. Argentino, G. Lenzi, M. Sacchetti, D. Toni, L. Bozzao (1989)
Clinical and instrumental evaluation of patients with ischemic stroke within the first six hoursJournal of the Neurological Sciences, 91
Mona Britton, Asa Roden (1985)
Progression of stroke after arrival at hospital.Stroke, 16 4
V. Larrue (2000)
[Guidelines for the use of intravenous thrombolytic therapy cerebrovascular ischemic accident. French Society for Neurovascular Disease].Presse medicale, 29 7
(1995)
Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric strokeJAMA, 274
P. Schellinger, O. Jansen, J. Fiebach, S. Heiland, T. Steiner, S. Schwab, Olivia Pohlers, H. Ryssel, K. Sartor, W. Hacke (2000)
Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI.Stroke, 31 6
W. Koroshetz, M. Moskowitz (1996)
Emerging treatments for stroke in humans.Trends in pharmacological sciences, 17 6
J. Grotta, M. Kothari, K. Welch, J. Broderick, B. Tilley, T. Brott, Marler, P. Lyden, P. O'Byrne (1995)
Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.The New England Journal of Medicine
(1996)
Thrombolytic therapy with streptokinase in acute ischaemic strokeNew Engl JMed, 335
M. Lu, B. Tilley (2001)
Use of odds ratio or relative risk to measure a treatment effect in clinical trials with multiple correlated binary outcomes: data from the NINDS t‐PA stroke trialStatistics in Medicine, 20
G. Donnan, Stephen Davis, Brian Chambers, Peter Gates, Graeme Hankey, John McNeil, D. Rosen, E. Stewart-Wynne, Roger Tuck (1996)
Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group.JAMA, 276 12
E. Haley, T. Brott, George Sheppard, W. Barsan, Joseph Broderick, J. Marler, Gail Kongable, J. Spilker, S. Massey, C. Hansen (1993)
Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke. The TPA Bridging Study Group.Stroke, 24 7
G. Zoppo, R. Higashida, A. Furlan, M. Pessin, H. Rowley, M. Gent (1998)
PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism.Stroke, 29 1
J.R. Marler, B.C. Tilley, M. Lu (2000)
Early stroke treatment associated with better outcome. The NINDS rt-PA Stroke StudyNeurology, 55
E. Mori, Y. Yoneda, M. Tabuchi, T. Yoshida, S. Ohkawa, Y. Ohsumi, K. Kitano, A. Tsutsumi, A. Yamadori (1992)
Intravenous recombinant tissue plasminogen activator in acute carotid artery territory strokeNeurology, 42
(2000)
Recommandations pour l’utilisation du traitement thrombolytique intraveineux dans l’accident ischémique cérébralPresse Med, 29
D. Toni, M. Fiorelli, M. Gentile, S. Bastianello, M. Sacchetti, C. Argentino, C. Pozzilli, C. Fieschi (1995)
Progressing neurological deficit secondary to acute ischemic stroke. A study on predictability, pathogenesis, and prognosis.Archives of neurology, 52 7
D.G. Altman, J.J. Deeks, D.L. Sackett (1998)
Odds ratios should be avoided when events are common [letter]BMJ, 317
M. Hommel, C. Cornu, F. Boutitie, J. Boissel (1996)
Thrombolytic therapy with streptokinase in acute ischemic stroke.The New England journal of medicine, 335 3
A.M. Buchan, P.A. Barber, N. Newcommon (2000)
Effectiveness of t-PA in acute ischemie stroke: Outcome relates to appropriatenessNeurology, 54
W.J. Koroshetz, M.A. Moskowitz (1996)
Emerging treatments for stroke and the ischaemic penumbraTrends Pharmacol Sci, 17
A. Jaillard, C. Cornu, A. Durieux (1999)
Hemorrhagic transformation in Acute Ischemie Stroke. The MAST-E StudyStroke, 30
V. Larrue (2000)
Recommandations pour l'utilisation du traitement thrombolytique intra-veineux dans l'accident ischémique cérébral. Société Française Neurovasculaire.Presse Medicale, 29
(1995)
Tissue plasminogen activator for acute ischemie strokeNew Engl J Med, 333
G. Albers, V. Bates, W. Clark, R. Bell, P. Verro, S. Hamilton (2000)
Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study.JAMA, 283 9
T. Olsen (1986)
Regional cerebral blood flow after occlusion of the middle cerebral arteryActa Neurologica Scandinavica, 73
W. Hacke, M. Kaste, C. Fieschi, R. Kummer, A. Dávalos, Dieter Meier, V. Larrue, E. Bluhmki, S. Davis, G. Donnan, D. Schneider, E. Díez-Tejedor, P. Trouillas (1998)
Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)The Lancet, 352
Available evidence of thrombolysis in acute ischemic stroke comes from a series of recent trials conducted in patients with acute stroke, and from a meta-analysis published in the Cochrane Library. The objective of this paper is to review the literature on tolerability and efficacy of thrombolytic therapy in patients with acute ischemic stroke, to find out what the level of evidence is for each thrombolytic drug, and what should consequently be done in the routine practice.
American Journal of Cardiovascular Drugs – Springer Journals
Published: Aug 17, 2012
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.